Hans Matter

5.0k total citations
102 papers, 3.5k citations indexed

About

Hans Matter is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Hans Matter has authored 102 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 41 papers in Computational Theory and Mathematics and 22 papers in Organic Chemistry. Recurrent topics in Hans Matter's work include Computational Drug Discovery Methods (41 papers), Chemical Synthesis and Analysis (16 papers) and Protein Structure and Dynamics (15 papers). Hans Matter is often cited by papers focused on Computational Drug Discovery Methods (41 papers), Chemical Synthesis and Analysis (16 papers) and Protein Structure and Dynamics (15 papers). Hans Matter collaborates with scholars based in Germany, France and United States. Hans Matter's co-authors include Gerhard Heßler, Tudor I. Oprea, Herman Schreuder, Horst Kessler, Friedemann Schmidt, Marc Nazaré, Jan Wenzel, Stefan Güssregen, David W. Will and Volkmar Wehner and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Hans Matter

101 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Matter Germany 33 1.9k 1.4k 804 531 385 102 3.5k
Charles H. Reynolds United States 33 1.9k 1.0× 1.1k 0.8× 1.0k 1.3× 473 0.9× 335 0.9× 88 4.2k
Juswinder Singh United States 31 3.1k 1.7× 974 0.7× 1.3k 1.6× 589 1.1× 343 0.9× 57 4.9k
Paul S. Charifson United States 29 2.9k 1.5× 1.3k 1.0× 726 0.9× 463 0.9× 216 0.6× 55 4.0k
Douglas B. Kitchen United States 24 2.5k 1.3× 1.7k 1.2× 900 1.1× 466 0.9× 260 0.7× 45 4.3k
Steven L. Dixon United States 27 2.3k 1.2× 2.1k 1.5× 972 1.2× 470 0.9× 386 1.0× 46 4.2k
Robert C. Rizzo United States 30 2.7k 1.4× 1.3k 0.9× 695 0.9× 566 1.1× 198 0.5× 63 4.6k
Harren Jhoti United Kingdom 32 3.7k 2.0× 1.7k 1.2× 864 1.1× 724 1.4× 527 1.4× 51 5.7k
Anna Vulpetti Switzerland 29 1.9k 1.0× 958 0.7× 930 1.2× 443 0.8× 424 1.1× 71 3.2k
Bruce L. Bush United States 14 2.2k 1.1× 937 0.7× 513 0.6× 563 1.1× 346 0.9× 21 3.3k
Jordi Mestres Spain 37 2.3k 1.2× 2.1k 1.5× 870 1.1× 475 0.9× 273 0.7× 139 4.5k

Countries citing papers authored by Hans Matter

Since Specialization
Citations

This map shows the geographic impact of Hans Matter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Matter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Matter more than expected).

Fields of papers citing papers by Hans Matter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Matter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Matter. The network helps show where Hans Matter may publish in the future.

Co-authorship network of co-authors of Hans Matter

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Matter. A scholar is included among the top collaborators of Hans Matter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Matter. Hans Matter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langevin, Maxime, Christoph Grebner, Stefan Güssregen, et al.. (2023). Impact of Applicability Domains to Generative Artificial Intelligence. ACS Omega. 8(25). 23148–23167. 13 indexed citations
2.
Wang, Nan, Shuo Zhang, Yafei Yuan, et al.. (2022). Molecular basis for inhibiting human glucose transporters by exofacial inhibitors. Nature Communications. 13(1). 2632–2632. 25 indexed citations
3.
Matter, Hans, et al.. (2022). Optimizing interactions to protein binding sites by integrating docking-scoring strategies into generative AI methods. Frontiers in Chemistry. 10. 1012507–1012507. 9 indexed citations
4.
Hoffmann, Holger, Herbert Kogler, Hans Matter, et al.. (2015). Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties. Angewandte Chemie International Edition. 54(35). 10145–10148. 70 indexed citations
5.
Kerdawy, Ahmed M. El, Stefan Güssregen, Hans Matter, Matthias Hennemann, & Timothy Clark. (2014). Quantum-mechanics-based molecular interaction fields for 3D-QSAR. Journal of Cheminformatics. 6(S1). O10–O10. 8 indexed citations
6.
Zöller, G., Hans Matter, Andreas W. Herling, et al.. (2013). Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1). European Journal of Pharmacology. 707(1-3). 140–146. 10 indexed citations
7.
Matter, Hans, et al.. (2013). Measuring Interference of Drug-Like Molecules with the Respiratory Chain: Toward the Early Identification of Mitochondrial Uncouplers in Lead Finding. Assay and Drug Development Technologies. 11(7). 408–422. 6 indexed citations
8.
Mittelmeier, Wolfram, et al.. (2012). Effect of Storage Temperature on Allograft Bone. Transfusion Medicine and Hemotherapy. 39(1). 36–40. 29 indexed citations
9.
Matter, Hans, et al.. (2012). Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules. Bioorganic & Medicinal Chemistry. 20(18). 5352–5365. 29 indexed citations
10.
Scheiper, Bodo, et al.. (2011). Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5480–5486. 16 indexed citations
11.
Keil, Stefanie, Hans Matter, Karl Schönafinger, et al.. (2011). Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator‐Activated Receptor (PPAR) γ/δ Agonists with High Potency and in vivo Efficacy. ChemMedChem. 6(4). 633–653. 17 indexed citations
12.
Scheiper, Bodo, et al.. (2010). Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6268–6272. 35 indexed citations
13.
Nazaré, Marc, David W. Will, Hans Matter, et al.. (2004). Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents. Bioorganic & Medicinal Chemistry Letters. 14(16). 4191–4195. 13 indexed citations
14.
Frank, Michael, Sabine Maier, Harald K. Rau, et al.. (2004). Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa. Analytical Biochemistry. 335(1). 50–57. 17 indexed citations
15.
Matter, Hans & Peter Kotsonis. (2004). Biology and chemistry of the inhibition of nitric oxide synthases by pteridine‐derivatives as therapeutic agents. Medicinal Research Reviews. 24(5). 662–684. 15 indexed citations
16.
Klingler, Otmar, Hans Matter, Manfred Schudok, et al.. (2004). Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition. Bioorganic & Medicinal Chemistry Letters. 14(14). 3715–3720. 15 indexed citations
17.
Nazaré, Marc, Hans Matter, Otmar Klingler, et al.. (2004). Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand. Bioorganic & Medicinal Chemistry Letters. 14(11). 2801–2805. 11 indexed citations
18.
Matter, Hans, et al.. (2001). Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(2). 227–230. 12 indexed citations
19.
Matter, Hans, et al.. (2001). Computational Approaches Towards the Rational Design of Drug-like Compound Libraries. Combinatorial Chemistry & High Throughput Screening. 4(6). 453–475. 46 indexed citations
20.
Matter, Hans, et al.. (1996). Compound libraries for lead discovery. 14(6). 9–15. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles H. Reynolds Breakdown of academic impact, for papers by Juswinder Singh Breakdown of academic impact, for papers by Paul S. Charifson Breakdown of academic impact, for papers by Douglas B. Kitchen Breakdown of academic impact, for papers by Steven L. Dixon Breakdown of academic impact, for papers by Robert C. Rizzo Breakdown of academic impact, for papers by Harren Jhoti Breakdown of academic impact, for papers by Anna Vulpetti Breakdown of academic impact, for papers by Bruce L. Bush Breakdown of academic impact, for papers by Jordi Mestres
Rankless by CCL
2026